title: Interferon-alpha treatment of patients with Hepatitis C: the role of a comprehensive risk-benefit assessment.
authors.forename: Muhamad Aly
authors.initials: MA
authors.lastname: Rifai
authors.forename: Jennifer M
authors.initials: JM
authors.lastname: Loftis
authors.forename: Peter
authors.initials: P
authors.lastname: Hauser
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D011994:Recombinant Proteins; D018570:Risk Assessment
chemical_list: D000998:Antiviral Agents; D007370:Interferon Type I; D011994:Recombinant Proteins